Mergers & Acquisitions ·
Organigram agrees to acquire Aurora Cannabis for C$7.80 per share in all-cash or stock deal
ACBAurora Cannabis Inc
Organigram Global Inc. has entered into an arrangement agreement to acquire Aurora Cannabis Inc. at a price of C$7.80 per Aurora common share, valuing the target at approximately C$561 million on a fully diluted basis. Shareholders may elect to receive the consideration in cash, Organigram shares (5.8626 per Aurora share), or a combination thereof, subject to proration limits of C$253.6 million in cash and 205.8 million shares. The offer represents a 93% premium to Aurora’s unaffected price on August 10, 2026, and supersedes a previously rejected hostile bid from Curaleaf. Both boards unanimously recommend the transaction, which is expected to close in January 2027 following shareholder and regulatory approvals. The combined entity will leverage Organigram’s recreational cannabis leadership and Aurora’s global medical cannabis platform to create a diversified international operator.